Total Funding
45
65
Total FundingSeries C raised
Growth Score 45 in past quarter
-29 pts
Heat Score 65 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
90318
SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.
- Ulrike Protzer: Scientific Co-Founder
- Frank Wang: Co-Founder, Chief Executive Officer
About the Company
SCG Cell Therapy's goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections and associated antigens. SCG Cell Therapy is committed to the development of novel immunotherapies for the treatment of patients with cancer and pathogenic infections.